Stockreport

Kite Presents New Data Underscoring Curative Potential of Yescarta® in Relapsed/Refractory Large B-cell Lymphoma at ASH [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF Broader Patient Population with Relapsed/Refractory Large B-cell Lymphoma (R/R LBCL) – – RWE Shows Decreasing Trend Over Time of Cytokine Release Syndrome and Related [Read more]